产品说明书
WAY-620645
 |
同义名 : | CCK antagonist 1 |
| CAS号 : | 742116-45-6 | |
| 货号 : | A1217665 | |
| 分子式 : | C22H22N4O2 | |
| 纯度 : | 99%+ | |
| 分子量 : | 374.43 | |
| MDL号 : | - | |
| 存储条件： |
粉末 Sealed in dry,Store in freezer, under -20°C 液体 -20°C:3-6个月-80°C:12个月 |
|
| 溶解度 : | - | |
| 动物实验配方： |
| 生物活性 | |||
|---|---|---|---|
| 描述 | CCK antagonist 1 is a CCK antagonist with IC50s of 1.1 μM and 4 μM for CCK1 and CCK2, respectively, which is utilized in cancer and mental disease research[1]. | ||
| 实验方案 | |||
|---|---|---|---|
| 1mg | 5mg | 10mg | |
|
1 mM 5 mM 10 mM |
2.67mL 0.53mL 0.27mL |
13.35mL 2.67mL 1.34mL |
26.71mL 5.34mL 2.67mL |
| 参考文献 |
|---|
|
[1]Eric Lattmann, et al. Novel ureido - and amido-pyrazolone derivatives. Patent WO2004106306A1. |